Covalent binding of hydroxy-alkenals 4-HDDE, 4-HHE, and 4-HNE to ethanolamine phospholipid subclasses

Journal of Lipid Research

Volumn 44, Issue 5, 2003, Pages 917-926

  Bacot, Sandrine ^b   Bernoud Hubac, Nathalie ^b   Baddas, Naïma ^b   Chantegrel, Bernard ^a   Deshayes, Christian ^a   Doutheau, Alain ^a   Lagarde, Michel ^b   Guichardant, Michel ^b  

^a UNIVERSITÉ DE LYON   (France)

^b NONE

Author keywords

4 hydroxy 2E hexenal; 4 hydroxy 2E nonenal; 4 hydroxydodeca (2E,6Z) dienal

Indexed keywords

15 HYDROPEROXYARACHIDONIC ACID; 4 HYDROXYDODECADIENAL; 4 HYDROXYHEXENAL; 4 HYDROXYNONENAL; ALDEHYDE; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ETHANOLAMINE; FATTY ACID; GLYCEROPHOSPHOETHANOLAMINE; PHOSPHOLIPID; PLASMALOGEN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN; COVALENT BOND; HUMAN; HUMAN CELL; HYDROPHOBICITY; LIPID OXIDATION; NONHUMAN; PLASMA; PRIORITY JOURNAL; RAT; SYNTHESIS;

ALDEHYDES; ANIMALS; BINDING SITES; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EICOSAPENTAENOIC ACID; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; PHOSPHATIDYLETHANOLAMINES; PHOSPHOLIPIDS; RATS; TIME FACTORS;

EID: 0142105855     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200450-JLR200     Document Type: Article

References (57)

1. Sun, G. Y., and L. A. Horrocks. 1969. Acyl and alk-1-enyl group compositions of the alk-1′-enyl acyl and the diacyl glycerophosphorylethanolamines of mouse and ox brain. J. Lipid. Res. 10: 153-157.
2. Horrocks. L. A. 1972. Ether Lipids. Chemistry and Biology. E Snyder, editor. Academic Press, New York. 177-272.
3. Favreliere, S., L. Barrier, G. Durand, S. Chalon, and C. Tallineau. 1998. Chronic dietary n-3 polyunsaturated fatty acids deficiency affects the fatty acid composition of plasmenylethanolamine and phosphatidylethanolamine differently in rat frontal cortex, striatum, and cerebellum. Lipids. 33: 401-407.
4. Favreliere, S., S. Stadelmann-Ingrand, F. Huguet, D. De Javel, A. Piriou, C. Tallineau, and G. Durand. 2000. Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus. Neurobiol. Aging. 21: 653-660.
5. Zoeller, R. A., O. H. Morand, and C. R. Raetz. 1988. A possible role for plasmalogens in protecting animal cells against photosensitized killing. J. Biol. Chem. 263: 11590-11596.
6. Zommara, M., N. Tachibana, K. Mitsui, M. Sakono, I. Ikeda, and K. Imaizumi. 1995. Inhibitory effect of ethanolamine plasmalogen on iron and copper-dependent lipid peroxidation. Free Radic. Biol. Med. 18: 599-602.
7. Reiss, D., K. Beyer, and B. Engelmann. 1997. Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro. Biochem. J. 323: 807-814.
8. Sindelar, P. J., Z. Guan, G. Dallner, and L. Ernster. 1999. The protective role of plasmalogens in iron-induced lipid peroxidation. Free Radic. Biol. Med. 26: 318-324.
9. Bryant, R. W., and J. M. Bailey. 1980. Altered lipoxygenase metabolism and decreased glutathione peroxydase activity in platelets from selenium deficient rats. Biochem. Biophys. Res. Commun. 92: 268-276.
10. Vericel, E., C. Rey, C. Calzada, P. Haond, P. H. Chapuy, and M. Lagarde. 1992. Age-related changes in arachidonic acid peroxidation and glutathione-peroxidase activity in human platelets. Prostaglandins. 43: 75-85.
11. Muruganandam, A., C. Drouillard, R. J. Thibert, R. M. Cheung, T. F. Draisey, and B. Mutus. 1992. Glutathione metabolic enzyme activities in diabetic platelets as a function of glycemic control. Thromb. Res. 67: 385-397.
12. Esterbauer, H. 1982. Aldehydic Products of Lipid Peroxidation: Free Radicals Lipid Peroxidation and Cancer. D. C. H. McBrien and T. F. Slater, editors. Academic Press, London. 101-128.
13. Poli, G., M. U. Dianzani, K. H. Cheeseman, T. F. Slater, J. Lang, and H. Esterbauer. 1985. Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or ADP-iron in isolated rat hepatocytes and rat liver microsomal suspensions. Biochem. J. 227: 629-638.
14. Van Kuijk, F. J., L. L. Holte, and E. A. Dratz. 1990. 4-Hydroxyhexenal: a lipid peroxidation product derived from oxidized docosahexaenoic acid. Biochim. Biophys. Acta 1043: 116-118.
15. Vieira, O., I. Escargueil-Blanc, G. Jurgens, C. Borner, L. Almeida, R. Salvayre, and A. Negre-Salvayre. 2000. Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway: potential role in oxidized LDL-induced apoptosis. FASEB J. 14: 532-542.
16. Al Abed, Y., H. Liebich, W. Voelter, and R. Bucala. 1996. Hydroxy-alkenal formation induced by advanced glycosylation of low density lipoprotein. J. Biol. Chem. 271: 2892-2896.
17. Grune, T., W. G. Siems, K. Schönheit, and I. E. Blasig. 1993. Release of 4-hydroxynonenal, an aldehydic mediator of inflammation, during postischaemic reperfusion of the myocardium. Int. J. Tissue React. 15: 145-150.
18. Di Mauro, C., G. Cavalli, M. Curzio, C. Ferretti, G. Mengozzi, M. A. Rossi, L. Paradisi, and M. U. Dianzani. 1995. Evidences of 4-hydroxy-nonenal involvement in modulation of phagocyte activities. Int. J. Tissue React. 17: 61-72.
19. Hamilton, R. F., Jr., L. Li, W. L. Eschenbacher, L. Szweda, and A. Holian. 1998. Potential involvement of 4-hydroxynonenal in the response of human lung cells to ozone. Am. J. Physiol. 274: L8-L16.
20. Montine, K. S., P. J. Kim, S. J. Olson, W. R. Markesbery, and T. J. Montine. 1997. 4-Hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease. J. Neuropathol. Exp. Neurol. 56: 866-871.
21. Odetti, P., S. Garibaldi, R. Norese, G. Angelini, L. Marinelli, S. Valentini, S. Menini, N. Traverso, D. Zaccheo, S. Siedlak, G. Perry, M. A. Smith, and M. Tabaton. 2000. Lipoperoxidation is selectively involved in progressive supranuclear palsy. J. Neuropathol. Exp. Neurol. 59: 393-397.
22. Lovell, M. A., W. D. Ehmann, M. P. Mattson, and W. R. Markesbery. 1997. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging. 18: 457-461.
23. Sayre, L. M., D. A. Zelasko, P. L. Harris, G. Perry, R. G. Salomon, and M. A. Smith. 1997. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68: 2092-2097.
24. Markesbery, W. R., and J. M. Carney. 1999. Oxidative alterations in Alzheimer's disease. Brain Pathol. 9: 133-146.
25. Morel, P., C. Tallineau, R. Pontcharraud, A. Piriou, and E. Huguet. 1998. Effects of 4-hydroxynonenal, a lipid peroxidation product, on dopamine transport and Na+/K+ ATPase in rat striatal synaptosomes. Neurochem. Int. 33: 531-540.
26. Szweda, L. I., K. Uchida, L. Tsai, and E. R. Stadtman. 1993. Inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Selective modification of an active-site lysine. J. Biol. Chem. 268: 3342-3347.
27. Nadkarni, D. V., and L. M. Sayre. 1995. Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal. Chem. Res. Toxicol. 8: 284-291.
28. Malle, E., A. Ibovnik, H.J. Leis, G. M. Kostner, P. F. Verhallen, and W. Sattler. 1995. Lysine modification of LDL or lipoprotein(a) by 4-hydroxynonenal or malondialdehyde decreases platelet serotonin secretion without affecting platelet aggregability and eicosanoid formation. Arterioscler. Thromb. Vasc. Biol. 15: 377-384.
29. Selley, M. L., M. R. Bartlett, A. L. Czeti, and N. G. Ardlie. 1998. The role of (E)-4-hydroxy-2-nonenal in platelet activation by low density lipoprotein and iron. Atherosclerosis. 140: 105-112.
30. Jessup, W., G. Jurgens, J. Lang, H. Esterbauer, and R. T. Dean. 1986. Interaction of 4-hydroxynonenal-modified low-density lipoproteins with the fibroblast apolipoprotein B/E receptor. Biochem. J. 234: 245-248.
31. Dogterom, P., G. J. Mulder, and J. F. Nagelkerke. 1989. Lipid peroxidation-dependent and -independent protein thiol modifications in isolated rat hepatocytes: differential effects of vitamin E and disulfiram. Chem. Biol. Interact. 71: 291-306.
32. Siems, W. G., H. Zollner, T. Grune, and H. Esterbauer. 1997. Metabolic fate of 4-hydroxynonenal in hepatocytes: 1,4-dihydroxynonene is not the main product. J. Lipid Res. 38: 612-622.
33. Del Corso, A., M. Dal Monte, P. G. Vilardo, I. Cecconi, R. Moschini, S. Banditelli, M. Cappiello, L. Tsai, and U. Mura. 1998. Site-specific inactivation of aldose reductase by 4-hydroxynonenal. Arch. Biochem. Biophys. 350: 245-248.
34. Friguet, B., E. R. Stadtman, and L. I. Szweda. 1994. Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease. J. Biol. Chem. 269: 21639-21643.
35. Winter, C. K., H. J. Segall, and W. F. Haddon. 1986. Formation of cyclic adducts of deoxyguanosine with the aldehydes trans-4-hydroxy-2-hexenal and trans-4-hydroxy-2-nonenal in vitro. Cancer Res. 46: 5682-5686.
36. Wacker, M., D. Schuler, P. Wanek, and E. Eder. 2000. Development of a (32)P-postlabeling method for the detection of 1,N(2)-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in vivo. Chem. Res. Toxicol. 13: 1165-1173.
37. Guichardant, M., P. Taibi-Tronche, L. B. Fay, and M. Lagarde. 1998. Covalent modifications of aminophospholipids by 4-hydroxy-nonenal. Free Radic. Biol. Med. 25: 1049-1056.
38. Fountain, W. C., J. R. Requena, A. J. Jenkins, T. J. Lyons, B. Smyth, J. W. Baynes, and S. R. Thorpe. 1999. Quantification of N-(glucitol) ethanolamine and N-(carboxymethyl) serine: two products of nonenzymatic modification of aminophospholipids formed in vivo. Anal. Biochem. 272: 48-55.
39. Hazen, S. L., J. P. Gaut, J. R. Crowley, F. F. Hsu, and J. W. Heinecke. 2000. Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions. Biochem. J. 352: 693-699.
40. Lagarde, M., P. A. Bryon, M. Guichardant, and M. Dechavanne. 1980. A simple and efficient method for platelet isolation from their plasma. Thromb. Res. 17: 581-588.
41. Kosower, N. S., E. M. Kosower, B. Wertheim, and W. S. Correa. 1969. Diamide, a new reagent for the intracellular oxidation of glutathione to the disulfide. Biochem. Biophys. Res. Commun. 37: 593-596.
42. Roth, G. J., and P. W. Majerus. 1975. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J. Clin. Invest. 56: 624-632.
43. Lang, J., C. Celotto, and H. Esterbauer. 1985. Quantitative determination of the lipid peroxidation product 4-hydroxynonenal by high-performance liquid chromatography. Anal. Biochem. 150: 369-378.
44. Van Kuijk, F. J., A. N. Siakotos, L. G. Fong, R.J. Stephens, and D. W. Thomas. 1995. Quantitative measurement of 4-hydroxyalkenals in oxidized low-density lipoprotein by gas chromatography-mass spectrometry. Anal. Biochem. 224: 420-424.
45. Juaneda, P., and G. Rocquelin. 1985. Rapid and convenient separation of phospholipids and non phosphorus lipids from rat heart using silica cartridges. Lipids. 20: 40-41.
46. Khaselev, N., and R. C. Murphy. 1999. Susceptibility of plasmenyl glycerophosphoethanolamine lipids containing arachidonate to oxidative degradation. Free Radic. Biol. Med. 26: 275-284.
47. Tanikaga, R., Y. Nozaki, T. Tamura, and A. Kaji. 1983. Facile synthesis of 4-hydroxy-(E)-2-alkenoic esters from aldehydes. Synthesis. 2: 134-135.
48. Burgess, K., and I. Henderson. 1990. Lipase-mediated resolutions of SPAC reaction products. Tetrahedron Asymmetry. 1: 57-60.
49. Gunn, B. P., and D. W. Brooks. 1985. Total synthesis of (+/-)-12-hydroxy-5(Z),8(Z),10(E),14(Z)-eicosatetraenoic acid (12-HETE). J. Org. Chem. 50: 4417-4418.
50. Uchida, K., H. Watanabe, and T. Kitahara. 2000. Synthesis of (+/-)-(3R*, 4S*, 4aR* )-4,8-dihydroxy-3-methyl-3,4,4a,5-tetrahydro-1H-2-benzopyran-1-one. Heterocycles. 53: 539-542.
51. Pryor, W. A., and N. A. Porter. 1990. Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids. Free Radic. Biol. Med. 8: 541-543.
52. Porter, N. A., S. E. Cadwell, and K. A. Mills. 1995. Mechanisms of free radical oxidation of unsaturated lipids. Lipids. 30: 277-290.
53. Hamberg, M., and B. Samuelsson. 1974. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc. Natl. Acad. Sci. USA. 71: 3400-3404.
54. Mosset, P., P. Yadagiri, S. Lumin, J. Capdevila, and J. R. Falck. 1986. Arachidonate epoxygenase: total synthesis of both enantiomers of 8,9- and 11,12-epoxyeicosatrienoic acid. Tetrahedron Lett. 27: 6035-6038.
55. Yadagiri, P., S. Lumin, P. Mosset, J. Capdevila, and J. R. Falck. 1986. Enantiospecific total synthesis of 8- and 12-hydroxyeicosatetraenoic acid. Tetrahedron Lett. 27: 6039-6040.
56. Han, X., and R. W. Gross. 1990. Plasmenylcholine and phosphatidylcholine membrane bilayers possess distinct conformational motifs. Biochemistry. 29: 4992-4996.
57. Guichardant, M., N. Bernoud-Hubac, B. Chantegrel, C. Deshayes, and M. Lagarde. 2002. Aldehydes from n-6 fatty acid peroxidation. Effect on aminophospholipids. Prostaglandins Leukot. Essent. Fatty Acids. 67: 147-149.